Peptide record

TPDB07312

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07312
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept APD_complete HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 13-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
IIPLPLGYFAKKT
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C73H117N15O16
RNDCEQHMSWV
ILKP
1460.82
10.20
2
0
7
+2
-0.89
0.600
127.69
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
1490
1.02
2
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
2
I
2
L
2
K
0
M
1
F
2
P
0
S
1
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 2 L: 2 K: 2 M: 0 F: 1 P: 2 S: 0 T: 1 W: 0 Y: 1 V: 0
Chemical Descriptors
13 reviewed residue count
C73H117N15O16 sequence-only estimate (linear, free termini)
1460.82 sequence-only estimate (linear, free termini)
10.20 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
-0.89 sequence-only estimate (linear, free termini)
0.600 sequence-only estimate (linear, free termini)
Evidence Records 15 records
Evidence 1 Activity

Activity

MIC
Antibacterial
6 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Strongly active against S. aureus (MIC 6 uM) and E. coli (MIC 3 uM). Conflict: Inactive against E.coli AS 1.349 (MIC > 100 uM), P.aeru
Evidence 2 Activity

Activity

MIC
Antibacterial
3 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Strongly active against S. aureus (MIC 6 uM) and E. coli (MIC 3 uM). Conflict: Inactive against E.coli AS 1.349 (MIC > 100 uM), P.aeruginosa CGMCC 1.860 (MIC
Evidence 3 Activity

Activity

MIC
Antibacterial
>100 µM

Target

Enterococcus faecalis

Source & Reference

dbAMP DRAMP

Other

1.72 (MIC > 100 uM), B.cereus AS 1.126 (MIC > 100 uM), S.lactis AS 1.1690 (MIC >100 uM), E.faecalis (MIC >100 uM), E.faecium CGMCC 1.2334 (MIC >100 uM) ( Ji et al., 2022 ).
Evidence 4 Activity

Activity

MIC
Antifungal
6 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Strongly active against S. aureus (MIC 6 uM) and E. coli (MIC 3 uM). Conflict: Inactive against E.coli AS 1.349 (MIC > 100 uM), P.aeru
Evidence 5 Activity

Activity

MIC
Antifungal
3 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP Antifungipept

Other

Strongly active against S. aureus (MIC 6 uM) and E. coli (MIC 3 uM). Conflict: Inactive against E.coli AS 1.349 (MIC > 100 uM), P.aeruginosa CGMCC 1.860 (MIC
Evidence 6 Activity

Activity

MIC
Antifungal
>100 µM

Target

Enterococcus faecalis

Source & Reference

dbAMP DRAMP Antifungipept

Other

1.72 (MIC > 100 uM), B.cereus AS 1.126 (MIC > 100 uM), S.lactis AS 1.1690 (MIC >100 uM), E.faecalis (MIC >100 uM), E.faecium CGMCC 1.2334 (MIC >100 uM) ( Ji et al., 2022 ).
Evidence 7 Activity

Activity

MIC
Antiparasitic
6 µM

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Strongly active against S. aureus (MIC 6 uM) and E. coli (MIC 3 uM). Conflict: Inactive against E.coli AS 1.349 (MIC > 100 uM), P.aeru
Evidence 8 Activity

Activity

MIC
Antiparasitic
3 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Strongly active against S. aureus (MIC 6 uM) and E. coli (MIC 3 uM). Conflict: Inactive against E.coli AS 1.349 (MIC > 100 uM), P.aeruginosa CGMCC 1.860 (MIC
Evidence 9 Activity

Activity

MIC
Antiparasitic
>100 µM

Target

Enterococcus faecalis

Source & Reference

DRAMP

Other

1.72 (MIC > 100 uM), B.cereus AS 1.126 (MIC > 100 uM), S.lactis AS 1.1690 (MIC >100 uM), E.faecalis (MIC >100 uM), E.faecium CGMCC 1.2334 (MIC >100 uM) ( Ji et al., 2022 ).
Evidence 10 Activity

Activity

MIC
Antiviral
6 µM

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Strongly active against S. aureus (MIC 6 uM) and E. coli (MIC 3 uM). Conflict: Inactive against E.coli AS 1.349 (MIC > 100 uM), P.aeru
Evidence 11 Activity

Activity

MIC
Antiviral
3 µM

Target

Escherichia coli

Source & Reference

DRAMP

Other

Strongly active against S. aureus (MIC 6 uM) and E. coli (MIC 3 uM). Conflict: Inactive against E.coli AS 1.349 (MIC > 100 uM), P.aeruginosa CGMCC 1.860 (MIC
Evidence 12 Activity

Activity

MIC
Antiviral
>100 µM

Target

Enterococcus faecalis

Source & Reference

DRAMP

Other

1.72 (MIC > 100 uM), B.cereus AS 1.126 (MIC > 100 uM), S.lactis AS 1.1690 (MIC >100 uM), E.faecalis (MIC >100 uM), E.faecium CGMCC 1.2334 (MIC >100 uM) ( Ji et al., 2022 ).
Evidence 13 Activity

Activity

50% Hemolysis
Toxicity
>500 µM
Hemolytic Cytotoxic
50% Hemolysis | >500 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Membrane mechanism of temporin-1CEc, an antimicrobial peptide isolated from the skin secretions of Rana chensinensis, and its systemic analogs. | Bioorg Chem | 2022
Evidence 14 Activity

Activity

50% Hemolysis
Toxicity
>300 µM
Hemolytic Cytotoxic
50% Hemolysis | >300 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evidence 15 Hemolysis

Source & Reference

APD_complete HemoPI PD_Hemolysis
APD_complete PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation.